Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-26 Sale |
2023-09-28 5:30 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
6,000,000 | $0.5 | $3,000,000 | 17,652,466 (Indirect) |
View |
| 2022-08-29 Sale |
2022-08-31 7:03 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
500,000 | $5.3145 | $2,657,240 | 23,652,466 (Indirect) |
View |
| 2021-12-28 Sale |
2021-12-30 5:12 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
2,764 | $8.5101 | $23,522 | 24,152,466 (Indirect) |
View |
| 2021-12-23 Sale |
2021-12-28 08:11 am |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
81,787 | $8.5547 | $699,666 | 24,155,230 (Indirect) |
View |
| 2021-12-09 Sale |
2021-12-10 4:08 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
23,660 | $8.5605 | $202,541 | 24,237,017 (Indirect) |
View |
| 2021-12-07 Sale |
2021-12-09 4:08 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
127,992 | $8.5885 | $1,099,265 | 24,260,677 (Indirect) |
View |
| 2021-12-01 Sale |
2021-12-03 4:09 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
2,604 | $8.5123 | $22,166 | 24,388,669 (Indirect) |
View |
| 2021-11-26 Sale |
2021-11-30 4:20 pm |
SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner |
28,884 | $8.6011 | $248,434 | 24,391,273 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-01-11 4:30 pm |
N/A N/A |
Sage Therapeutics Inc. | SAGE | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 6,241,473 (Indirect) |
View |
Ownership |
2020-09-28 4:30 pm |
N/A N/A |
Denali Therapeutics Inc. | DNLI | BIOGEN INC. Biogen MA Inc. 10% Owner |
0 | $0 | 13,310,243 (Indirect) |
View |